Inventor
THIM LARS
DK18 patents
⚠️ This page may combine multiple inventors who share the name “THIM LARS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVO NORDISK AS
12 patentsUS5705482AJan 6, 1998
Pharmaceutical formulation
NOVO NORDISK AS70 citations95
US5912229AJun 15, 1999
Use of a pharmaceutical composition comprising an appetite-suppressing peptide
NOVO NORDISK AS112 citations94
US7411039B2Aug 12, 2008
GLP-2 compounds, formulations, and uses thereof
NOVO NORDISK AS69 citations93
US5783416AJul 21, 1998
Human spasmolytic polypeptide in glycosylated form
NOVO NORDISK AS46 citations91
US5175113ADec 29, 1992
Modified β2 -microglobulin
NOVO NORDISK AS21 citations78
US5552385ASep 3, 1996
Pharmaceutical formulation
NOVO NORDISK AS10 citations71
US6022858AFeb 8, 2000
Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
NOVO NORDISK AS11 citations70
US5051371ASep 24, 1991
Modified β2 -microglobulin
NOVO NORDISK AS14 citations70
US9150848B2Oct 6, 2015
Conjugated factor VIII molecules
NOVO NORDISK AS1 citations48
US8536126B2Sep 17, 2013
Conjugated factor VIII molecules
NOVO NORDISK AS1 citations48
US6458927B1Oct 1, 2002
Polypeptide with appetite regulating activity
NOVO NORDISK AS1 citations46
US9125890B2Sep 8, 2015
Compounds suitable for treatment of haemophilia
NOVO NORDISK AS0 citations40
NOVO INDUSTRI AS
5 patentsUS4916212AApr 10, 1990
DNA-sequence encoding biosynthetic insulin precursors and process for preparing the insulin precursors and human insulin
NOVO INDUSTRI AS75 citations93
US4826763AMay 2, 1989
Process for preparing glucagon or fragments or derivatives thereof in yeast
NOVO INDUSTRI AS26 citations90
US4370317AJan 25, 1983
Pancreatic spasmolytic polypeptide
NOVO INDUSTRI AS27 citations78
US4816441AMar 28, 1989
Peptides and compositions
NOVO INDUSTRI AS17 citations71
US4405608ASep 20, 1983
Novel peptide
NOVO INDUSTRI AS4 citations59